RESUMEN
This commentary looks at the Kerala Public Health Act (KPHA), passed on November 28, 2023, through the lens of public health ethics. While the Act recognises the importance of prevention and strengthening of social systems, it falters in the public health ethics and human rights framework, ignoring international public health principles such as the Siracusa Principles and guidelines for individual diseases such as tuberculosis. The Covid-19 pandemic in India itself offers ample learnings, which have been disregarded, on the need for caution against state overreach. Principles such as autonomy, privacy/confidentiality, transparency, accountability, rule of law, least harm etc have not even been given token consideration, making this law a potential tool of abuse, particularly against already vulnerable communities.
Asunto(s)
COVID-19 , Salud Pública , Humanos , India , COVID-19/prevención & control , Salud Pública/ética , Salud Pública/legislación & jurisprudencia , SARS-CoV-2 , Derechos Humanos/legislación & jurisprudencia , PandemiasRESUMEN
In the spring of 2024, the federal government is expected to report on its legislative review of the Cannabis Act (2018). One of the most contentious issues is whether to relax restrictions on cannabis promotion. This commentary describes the tension between the public health aims of legalization and the secondary aim of displacing the illicit market. We maintain that among jurisdictions that have legalized cannabis, Canada stands out as having the stated primary objective of safeguarding public health, and its restrictions on promotion are evidence-based and innovative. These measures must be preserved, even in the face of growing industry pressure to loosen them.
Asunto(s)
Cannabis , Legislación de Medicamentos , Humanos , Canadá , Salud Pública/legislación & jurisprudenciaRESUMEN
Union activism, medical lobbying and occupational health and safety prosecutions led to a major public health initiative in Australia - the banning from 1 July 2024 of work with engineered/artificial stone, including manufacturing, supplying, processing and installing it. This editorial contextualises within the history of regulation of workers' exposure to risks of contracting silicosis the growing international awareness of the dangers posed by working with engineered stone, particularly in relation to making and installing kitchen and bathroom benchtops made from engineered stone. It argues that the Australian initiative is an important public health decision that has a sound justification, is likely to save many lives and should be emulated internationally.
Asunto(s)
Salud Pública , Australia , Humanos , Salud Pública/legislación & jurisprudencia , Exposición Profesional/legislación & jurisprudencia , Salud Laboral/legislación & jurisprudenciaRESUMEN
BACKGROUND: Punitive legal responses to prenatal drug use may be associated with unintended adverse health consequences. However, in a rapidly shifting policy climate, current information has not been summarized. We conducted a survey of U.S. state policies that utilize criminal or civil legal system penalties to address prenatal drug use. We then systematically identified empirical studies evaluating these policies and summarized their potential public health impacts. METHODS: Using existing databases and original statutory research, we surveyed current U.S. state-level prenatal drug use policies authorizing explicit criminalization, involuntary commitment, civil child abuse substantiation, and parental rights termination. Next, we systematically identified quantitative associations between these policies and health outcomes, restricting to U.S.-based peer-reviewed research, published January 2000-December 2022. Results described study characteristics and synthesized the evidence on health-related harms and benefits associated with punitive policies. Validity threats were described narratively. RESULTS: By 2022, two states had adopted policies explicitly authorizing criminal prosecution, and five states allowed pregnancy-specific and drug use-related involuntary civil commitment. Prenatal drug use was grounds for substantiating civil child abuse and terminating parental rights in 22 and five states, respectively. Of the 16 review-identified articles, most evaluated associations between punitive policies generally (k = 12), or civil child abuse policies specifically (k = 2), and multiple outcomes, including drug treatment utilization (k = 6), maltreatment reporting and foster care entry (k = 5), neonatal drug withdrawal syndrome (NDWS, k = 4) and other pregnancy and birth-related outcomes (k = 3). Most included studies reported null associations or suggested increases in adverse outcome following punitive policy adoption. CONCLUSIONS: Nearly half of U.S. states have adopted policies that respond to prenatal drug use with legal system penalties. While additional research is needed to clarify whether such approaches engender overt health harms, current evidence indicates that punitive policies are not associated with public health benefits, and therefore constitute ineffective policy.
Asunto(s)
Salud Pública , Trastornos Relacionados con Sustancias , Humanos , Estados Unidos , Embarazo , Femenino , Trastornos Relacionados con Sustancias/epidemiología , Salud Pública/legislación & jurisprudencia , Encuestas y Cuestionarios , Derecho PenalRESUMEN
This Viewpoint describes implications for medicine and public health if the US Supreme Court decides to overturn or narrow Chevron deference.
Asunto(s)
Regulación Gubernamental , Salud Pública , Decisiones de la Corte Suprema , United States Government Agencies , Humanos , COVID-19/prevención & control , Salud Pública/legislación & jurisprudencia , Estados Unidos , United States Government Agencies/legislación & jurisprudencia , Vacunas contra la COVID-19/uso terapéuticoAsunto(s)
Gobierno Federal , Política , Política Pública , Ciencia , Política Pública/legislación & jurisprudencia , Política Pública/tendencias , Estados Unidos , Ciencia/legislación & jurisprudencia , Ciencia/tendencias , Política Ambiental/legislación & jurisprudencia , Política Ambiental/tendencias , Salud Pública/legislación & jurisprudencia , Salud Pública/tendenciasRESUMEN
OBJECTIVE: Washington State legislators have attempted to regulate high delta-9-tetrahydrocannabinol (THC) cannabis to reduce cannabis-related harms. Historically, industry actors of other health-compromising products have influenced governments' adoption of evidence-based regulation policies. A better understanding of the industry rhetoric can be used by public health advocates to develop counterarguments and disseminate alternative narratives that protect the public's health. We analyzed the arguments used by cannabis industry actors opposing regulations to de-incentivize the availability and use of high-THC products in Washington State. METHOD: We analyzed 41 testimonies transcribed from 33 cannabis industry actors in 3 public bill hearings and one legislative work session that occurred between 2020 and 2023. Using a deductive thematic analysis, informed by industry actors' arguments opposing regulation of alcohol, tobacco, and high-sugar beverages, we developed a codebook to analyze and identify themes within cannabis industry rhetorical strategies. RESULTS: We identified three main rhetorical strategies used by cannabis industry actors to oppose THC content regulation: threaten, distract, discredit. The most frequently used rhetorical strategy was threats to economic benefits, public health, and the will of the people. The other two most apparent strategies were distracting from the bill's focus by introducing a tangential topic and discrediting the science that supported regulation of cannabis products with high THC concentration or its advocates. CONCLUSIONS: Cannabis industry actors have leveraged several arguments used by industry actors of other health-compromising products to undermine initiatives to advance public health. They have also adapted rhetoric from other industries to the unique conditions of the cannabis regulatory landscape.
Asunto(s)
Cannabis , Dronabinol , Washingtón , Humanos , Legislación de Medicamentos , Industria Farmacéutica/legislación & jurisprudencia , Salud Pública/legislación & jurisprudenciaRESUMEN
This Viewpoint discusses the importance of safeguarding health access in times armed conflict worldwide and the need to bolster compliance with international humanitarian law.
Asunto(s)
Conflictos Armados , Accesibilidad a los Servicios de Salud , Derecho Internacional , Salud Pública , Guerra , Conflictos Armados/legislación & jurisprudencia , Guerra/legislación & jurisprudencia , Salud Pública/legislación & jurisprudencia , Medio Oriente , Accesibilidad a los Servicios de Salud/legislación & jurisprudencia , Internacionalidad , Actitud Frente a la Salud , AltruismoRESUMEN
Studies of public health decisions that have had harmful effects tend to disagree about what constitutes a public health error. Debates exist about whether public health errors must be culpable or not, as well as about what the criteria for judging public health errors should be.
Asunto(s)
Salud Pública , Humanos , Salud Pública/legislación & jurisprudenciaRESUMEN
This Viewpoint discusses how federal vaccine requirements have helped thwart vaccine-preventable diseases as well as how growing public resistance to vaccines and judicial and legislative limits to vaccination mandates may change that.
Asunto(s)
Programas de Inmunización , Programas Obligatorios , Salud Pública , Vacunación , Vacunas , Programas de Inmunización/legislación & jurisprudencia , Programas de Inmunización/métodos , Programas Obligatorios/legislación & jurisprudencia , Salud Pública/legislación & jurisprudencia , Salud Pública/métodos , Vacunación/legislación & jurisprudencia , Vacunación/métodos , Vacunas/uso terapéuticoAsunto(s)
Brotes de Enfermedades , Aprobación de Drogas , Urgencias Médicas , Salud Pública , Humanos , Brotes de Enfermedades/legislación & jurisprudencia , Salud Pública/legislación & jurisprudencia , Estados Unidos/epidemiología , Urgencias Médicas/epidemiología , Aprobación de Drogas/legislación & jurisprudenciaRESUMEN
Endocrine disruptors are substances capable of interfering with our hormonal system, leading to deleterious effects. Given the many sources of exposure, the challenge is to understand the role played by these substances in the development of certain pathologies. Assessing their effects on health is therefore a scientific challenge and an important public health issue.
Asunto(s)
Disruptores Endocrinos , Exposición a Riesgos Ambientales , Salud Pública , Humanos , Disruptores Endocrinos/toxicidad , Exposición a Riesgos Ambientales/efectos adversos , Exposición a Riesgos Ambientales/ética , Exposición a Riesgos Ambientales/legislación & jurisprudencia , Salud Pública/ética , Salud Pública/legislación & jurisprudenciaRESUMEN
Societies generally have reacted to deadly epidemics by strengthening health systems, including laws. Under American federalism (the constitutional division of power between states and the federal government), individual states hold primary public health powers. State legislatures have historically granted health officials wide-ranging authority. After the anthrax attacks in the United States in 2001, the US Centers for Disease Control and Prevention (CDC) supported the Model State Emergency Health Powers Act, which granted public health officials even more expansive powers to declare a health emergency and respond swiftly. But all that ended with COVID-19, as state legislatures and courts gutted this authority. The next pandemic could be far deadlier than COVID-19, but when the public looks to federal and state governments to protect them, they may find that health officials have their hands tied behind their backs.
Asunto(s)
Administración en Salud Pública , Salud Pública , Gobierno Estatal , Humanos , COVID-19/prevención & control , Gobierno Federal , Pandemias/prevención & control , Salud Pública/legislación & jurisprudencia , Estados Unidos , Administración en Salud Pública/legislación & jurisprudenciaRESUMEN
This Viewpoint looks back at the US Supreme Court's 2021 and 2022 terms and forward to the 2023 term and beyond with a focus on decisions that affect health care, public health and safety, environmental policy, and social equity.